Special Issue “Cyclodextrins and Their Derivatives: A Basis for New Drug Formulations”

Posted by

This Special Issue in Molecules aims to implement the information regarding the use of cyclodextrins and their molecular complexes to evaluate their potential role in multiple applications.


Prof. Dr. Thomas Mavromoustakos
Department of Chemistry, National & Kapodistrian University of Athens, Athens, Greece
Interests: hypertension; structure elucidation; nuclear magnetic resonance; spectroscopy; NMR spectroscopy; medicinal and pharmaceutical chemistry; molecular modeling; Raman spectroscopy; DSC; NMR structure elucidation

Dr. Andreas Tzakos
Department of Chemistry, University of Ioannina, Ioannina, Greece
Interests: development of tumor-homing and tumor-responsive drug delivery vehicles as theranostics; drug formulations and prodrugs; development of imaging agents for visualizing and charting cellular compartments; pharmacokinetics (LC-MS, HPLC-based) and bioactivity evaluation; design and development of cancer diagnostics and theranostics; development of tumor-homing probes equipped with multimodal imaging agents (for MRI, in vivo near-infrared I & II optical imaging, and SPECT/PET probes)

Prof. Dr. Georgia N. Valsami
Department of Pharmacy, National & Kapodistrian University of Athens, Athens, Greece
Interests: drug-protein binding; drug-cyclodextrins interaction, characterization and effect on drug solubility/dissolution/absorption; Development and in vitro-in vivo evaluation of novel dosage forms with optimized absorption (GI/nasal/pulmonary); PK/PD studies and dosage individualization

Submissions before 31 March 2022: 400 CHF discount.

Website: https://www.mdpi.com/journal/molecules/special_issues/drug_cyclodextrin

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.